Do Proliferating Cell Nuclear Antigen and MIB-1/Ki-67 Have Prognostic Value in Penile Squamous Cell Carcinoma?

Urology

Volumn 70, Issue 1, 2007, Pages 137-142

  Guimarães, Gustavo Cardoso ^a   de Oliveira Leal, Marcos Lima ^a   Sousa Madeira Campos, Rodrigo ^a   de Cássio Zequi, Stênio ^a   da Fonseca, Francisco Paulo ^a   da Cunha, Isabela Werneck ^a   Soares, Fernando Augusto ^a   Lopes, Ademar ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; KI 67 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; METASTASIS; PENIS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; UNIVARIATE ANALYSIS;

CARCINOMA, SQUAMOUS CELL; HUMANS; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PENILE NEOPLASMS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 34447519884     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.03.003     Document Type: Article

References (30)

1. International Union Against Cancer. TNM Classification of Malignant Tumours: Penis. 6th ed. (2002), International Union Against Cancer, Geneva
2. Ornellas A.U., Seixas A.L.C., Marota A., et al. Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol 151 (1994) 1244-1249
3. Lopes A., Rossi B.M., Fonseca F.P., et al. Unreliability of modified inguinal lymphadenectomy for clinical staging of penile carcinoma. Cancer 77 (1996) 2099-2102
4. Hall M.C., Sanders J.S., Vuitch F., et al. Deoxyribonucleic acid flow cytometry and traditional pathologic variables in invasive penile carcinoma assessment of prognostic significance. Urology 52 (1998) 11-16
5. Fraley E.E., Zhang G., Manivel C., et al. The role of ilioinguinal lymphadenectomy and significance of histological differentiation in treatment of carcinoma of the penis. J Urol 142 (1989) 1478-1482
6. Slaton J.W., Morgenstern N., Levy D.A., et al. Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol 156 (2001) 1138-1142
7. Srinivas V., Morse M.J., Herr H.W., et al. Penile cancer: relation of extent of metastasis to survival. J Urol 137 (1987) 880-882
8. Solsona E., Iborra I., Ricos J.V., et al. Corpus cavernosum invasion and tumor grade in the prediction of lymph node condition in penile carcinoma. Eur Urol 22 (1992) 115-118
9. Horenblas S., and Van Tinteren H. Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol 151 (1994) 1239-1243
10. Narayama A.S., Olney L.E., Loening A.S., et al. Carcinoma of the penis: analysis of 219 cases. Cancer 49 (1982) 2185-2191
11. Lopes A., Hildago G.S., Kowalski L.P., et al. Prognostic factors in carcinoma of penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol 156 (1996) 1637-1642
12. Young M.J., Reda D.J., and Walters W.B. Penile carcinoma: a twenty-five-year experience. Urology 38 (1991) 529-532
13. Sufrin G., and Huben R. Benignant and malignant lesions of the penis. In: Gillewnateer J.Y. (Ed). Adult and Pediatric Urology. 2nd ed. (1987), Year Book Medical, Chicago 1462-1463
14. Waseem N.H., and Lane D.P. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA): structural conservation and the detection of a nucleolar form. J Cell Sci 96 (1990) 121-129
15. Dervan P.A., Magee H.M., Burkley C., et al. Proliferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue. Am J Clin Pathol 97 suppl 1 (1992) 21-28
16. Martins A.C.P., Faria S.M., Velludo M.A.L., et al. Carcinoma of the penis: the value of proliferating cell nuclear antigen (PCNA). Int Braz J Urol 26 (2000) 38-42
17. Martins A.C.P., Faria S.M., Cologna A.J., et al. Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J Urol 167 (2002) 89-93
18. Rowlands J. The effect of tissue fixation on immunostaining for proliferation cell nuclear antigen with the monoclonal antibody PC10. J Pathol 165 (1991) 356-357
19. Hall P.A., Levison D.A., Woods A.L., et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162 (1990) 285-294
20. Bravo R., and Macdonald-Bravo H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 105 (1987) 1549-1554
21. Mello E.S. Tempo de fixação e resultados imuno-histoquimicos quando usada a recuperação de epitopos induzida pelo calor. J Bras Patol 33 suppl (1997) 9-15
22. McCormick D., Yu C., Hobbs C., et al. The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens. Histopathology 22 (1993) 543-547
23. Brown D.C., and Gatter K.C. Ki-67 protein: the immaculate deception?. Histopathology 40 (2002) 2-11
24. Palmqvist R., Sellberg P., Oberg A., et al. Low tumours cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers. Br J Cancer 79 (1999) 577-581
25. Kimura T., Tanaka S., Haruma K., et al. Clinical significance of MUC1 and E-cadherin expression, cellular proliferation and angiogenesis at the deepest invasive portion of colorectal cancer. Int J Oncol 16 (2000) 55-64
26. Ofner D., Grothaus A., Riedmann B., et al. MIB-1 in colorectal carcinomas: its evaluation by three different methods reveals lack of prognostic significance. Anal Cell Pathol 12 (1996) 61-70
27. Kyzer S., and Gordon P.H. Determination of proliferative activity in colorectal carcinoma using monoclonal antibody Ki-67. Dis Colon Rectum 40 (1997) 322-325
28. Faria S.M., Martins A.C.P., Velludo M.A.S.L., et al. Imunoespressão do Ki-67 no carcinoma do pênis. Acta Cir Bras 15 suppl 2 (2000) 31-33
29. Berdjis N., Meye A., Nippgen J., et al. Expression of Ki-67 in squamous cell carcinoma of the penis. BJU Int 96 (2005) 146-148
30. Hadway P., Kommu S.S., and Watkin N.A. Expression of Ki-67 in squamous cell carcinoma of the penis. BJU Int 96 (2005) 1146-1147